EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis

Jessica L Fairley iD, Dylan Hansen, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Diane Apostolopoulos, Jennifer Walker, Lauren V Host, Wendy Stevens, Mandana Nikpour, Laura Ross iD

ACR Open Rheumatology · 2025-04 · 7 (4)

DOI: 10.1002/acr2.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 21.04.2025. Verfasst von Jessica L Fairley und 10 weiteren Autor:innen. Beteiligte Einrichtung: The University of Melbourne and St. Vincent's Hospital Melbourne, Melbourne, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Melbourne, Australian Government, Royal Australasian College of Physicians.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our objective was to define the frequency and impact of multimorbidity in systemic sclerosis (SSc).

Method

Australian Scleroderma Cohort Study participants meeting American College of Rheumatology/EULAR criteria were included. Charlson Comorbidity Index scores were calculated at each visit, with multimorbidity defined as scores ≥4. Generalized estimating equations were used to model longitudinal data in multivariable models including age, sex, subclass, interstitial lung disease, and pulmonary arterial hypertension status. Survival was analyzed using Cox hazard modeling.

Results

Of 2,000 participants, 85% were female, 27% had diffuse SSc, and 20% had multimorbidity. Among those with multimorbidity, key comorbidities were hypertension (81%), dyslipidemia (67%), obstructive lung disease (50%), malignancy (49%), and ischemic heart disease (IHD) (40%). Multimorbidity was associated with worse survival (hazard ratio [HR] 1.57, 95% confidence interval [CI] 1.30–1.91, P < 0.01). Renal disease had the largest impact (HR 2.41, 95% CI 1.46–3.98, P < 0.01), followed by left ventricular dysfunction (HR 1.76, 95% CI 1.21–2.57, P < 0.01), anticoagulation (HR 1.64, 95% CI 1.28–2.08, P < 0.01), and IHD (HR 1.45, 95% CI 1.16–1.80, P < 0.01). In multivariable modeling, multimorbidity was associated with poorer physical function (regression coefficient [RC] +0.17 units, 95% CI 0.13–0.21, P < 0.01). Peripheral vascular disease had the largest impact on physical function (RC +0.26 units, 95% CI 0.18–0.34, P < 0.01), followed by left ventricular dysfunction (RC +0.23 units, 95% CI 0.14–0.33, P = 0.01), IHD (RC +0.22 units, 95% CI 0.17–0.28, P < 0.01), and obstructive lung disease (RC +0.19 units, 95% CI 0.14–0.24, P < 0.01).

Conclusion

Multimorbidity occurred in 20% of patients in a large SSc cohort and was an important determinant of both prognosis and physical function. Effective treatment of non‐SSc morbidity may improve outcomes for patients with SSc. image

Autor:innen und Institutionen

  • The University of Melbourne and St. Vincent's Hospital Melbourne, Melbourne, Australia.
  • St. Vincent's Hospital Melbourne, Melbourne, Australia.
  • University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
  • Monash Health and Monash University, Melbourne, Australia.
  • Royal Adelaide Hospital and Flinders University of South Australia, Adelaide, Australia.
  • Fiona Stanley Hospital, Murdoch, Australia.

ORCID-Profile: Jessica L Fairley, Laura Ross

Förderung

  • University of Melbourne
  • Australian Government
  • Royal Australasian College of Physicians
  • National Health and Medical Research Council

Zitieren

APA

Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. S., Apostolopoulos, D., Walker, J., Host, L. V., Stevens, W., Nikpour, M., & Ross, L. (2025). The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis. ACR Open Rheumatology, 7(4). https://doi.org/10.1002/acr2.70034

Vancouver

Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Apostolopoulos D, et al. The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis. ACR Open Rheumatology. 2025;7(4). doi:10.1002/acr2.70034

BibTeX
@article{Fairley2025,
  author = {Fairley, Jessica L and Hansen, Dylan and Proudman, Susanna and Sahhar, Joanne and Ngian, Gene-Siew and Apostolopoulos, Diane and Walker, Jennifer and Host, Lauren V and Stevens, Wendy and Nikpour, Mandana and Ross, Laura},
  title = {The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis},
  journal = {ACR Open Rheumatology},
  year = {2025},
  volume = {7},
  number = {4},
  doi = {10.1002/acr2.70034}
}
Kostenlos starten →